AstraZeneca PLC (NYSE:AZN)

70.07
Delayed Data
As of Mar 27
 +0.30 / +0.43%
Today’s Change
61.80
Today|||52-Week Range
82.68
-0.44%
Year-to-Date
SECTOR
Health Technology
INDUSTRY
Pharmaceuticals: Major
MARKET CAP
$88.5B

Company Description

AstraZeneca Plc is a global research-based biopharmaceutical company, which primarily focuses on the discovery, development and commercialization of prescription medicines for gastrointestinal, cardiovascular, neuroscience, respiratory and inflammation, oncology and infectious disease. The company sells products under the brands Atacand, Crestor, Onglyza, Nexium, Entocort, Losec, Merrem/Meronem, Carbocaine, Citanest, Diprivan, Marcaine/Sensorcaine. AstraZeneca was founded on April 6, 1999 and is headquartered in London, the United Kingdom.

Contact Information

AstraZeneca Plc
2 Kingdom Street
London London & South East W2 6BD
P:442076048000
Investor Relations:
442076048199

Employees

Shareholders

Mutual fund holders3.92%
Other institutional3.61%
Individual stakeholders--

Top Executives

Pascal SoriotChief Executive Officer & Executive Director
David SmithEVP-Global Operations & Information Services
Marc DunoyerChief Financial Officer & Executive Director
Briggs MorrisonChief Medical Officer
Edward BradleySenior VP-Research & Development

To view my watchlist

Not a member yet?

Sign up now for a free account